1.00Open1.00Pre Close0 Volume37 Open Interest17.50Strike Price0.00Turnover127.09%IV7.00%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry1.00Extrinsic Value100Contract SizeAmericanOptions Type0.5028Delta0.1459Gamma17.29Leverage Ratio-0.1021Theta0.0012Rho8.69Eff Leverage0.0086Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet